Mutation burden and tumor neoantigens in RCC patients (pts) treated with nivolumab.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590210384
